Literature DB >> 18248928

Detection of histologically proven peritoneal carcinomatosis with fused 18F-FDG-PET/MDCT.

Albert Dirisamer1, Wolfgang Schima, Martin Heinisch, Michael Weber, Hans Peter Lehner, Joerg Haller, Werner Langsteger.   

Abstract

OBJECTIVE: To evaluate peritoneal carcinomatosis in patients with gastrointestinal and gynecologic malignancies and to assess the diagnostic role for 18-FDG-PET and MDCT alone in comparison to the diagnostic accuracy of fused 18F-FDG-PET/MDCT by using surgical and histopathological findings as the standard of reference. METHODS AND
SUBJECTS: Sixty-two patients (13 males, 49 females; age range 43-81; mean age, 62 years with suspected peritoneal carcinomatosis were reviewed for the presence of peritoneal lesions on 18F-FDG-PET/MDCT scans (Discovery LS, GE Medical Systems). The results were compared with the histological findings at laparatomy. Thirty-one patients had peritoneal metastases, while 31 patients had negative histological findings at laparotomy.
RESULTS: CT detected peritoneal seeding in 26/31 patients, 18F-FDG-PET in 25/31 patients, and 18F-FDG-PET/MDCT in 30/31 patients, for a sensitivity of 88%, 88%, and 100%, respectively. False-positive findings were seen in MDCT in one patient, in 18F-FDG-PET in two patients, and in 18F-MDCT-PET/MDCT in one patient, for a specificity of 97%, 94%, and 97%, respectively.
CONCLUSION: Fused 18F-FDG-PET/MDCT is superior to MDCT and 18F-FDG-PET alone for the detection of peritoneal carcinomatosis especially in small lesions and it offers exact anatomic information for surgical treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18248928     DOI: 10.1016/j.ejrad.2007.11.032

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  21 in total

1.  Imaging spectrum of peritoneal carcinomatosis on FDG PET/CT.

Authors:  Ameya D Puranik; Nilendu C Purandare; Archi Agrawal; Sneha Shah; Venkatesh Rangarajan
Journal:  Jpn J Radiol       Date:  2014-08-14       Impact factor: 2.374

Review 2.  Imaging ovarian cancer and peritoneal metastases--current and emerging techniques.

Authors:  Stavroula Kyriazi; Stan B Kaye; Nandita M deSouza
Journal:  Nat Rev Clin Oncol       Date:  2010-04-13       Impact factor: 66.675

3.  FDG-PET/ceCT is useful to predict recurrence of Pseudomyxoma peritonei.

Authors:  Julien Dubreuil; Francesco Giammarile; Pascal Rousset; Naoual Bakrin; Guillaume Passot; Sylvie Isaac; Olivier Glehen; Andrea Skanjeti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-02-24       Impact factor: 9.236

4.  Role of Imaging in Peritoneal Surface Malignancies.

Authors:  Santosh Krishnamurthy; Raghav Balasubramaniam
Journal:  Indian J Surg Oncol       Date:  2016-06-08

Review 5.  Diagnostic accuracy of 18F-FDG PET/CT for detection of peritoneal carcinomatosis; a systematic review and meta-analysis.

Authors:  Seong-Jang Kim; Sang-Woo Lee
Journal:  Br J Radiol       Date:  2017-11-21       Impact factor: 3.039

Review 6.  Diagnostic performance of computed tomography and magnetic resonance imaging for detecting peritoneal metastases: systematic review and meta-analysis.

Authors:  Andrea Laghi; Davide Bellini; Marco Rengo; Fabio Accarpio; Damiano Caruso; Daniele Biacchi; Angelo Di Giorgio; Paolo Sammartino
Journal:  Radiol Med       Date:  2016-09-19       Impact factor: 3.469

7.  Oral gastrografin radiography for the evaluation of the functional impact of peritoneal carcinomatosis: Correlation with clinicopathological findings.

Authors:  Lie-Jun Mei; Lin-Wei Wang; Chao-Qun Huang; Xiao-Jun Yang; Yan Li
Journal:  Mol Clin Oncol       Date:  2015-06-09

8.  Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT.

Authors:  Katrijn Michielsen; Ignace Vergote; Katya Op de Beeck; Frederic Amant; Karin Leunen; Philippe Moerman; Christophe Deroose; Geert Souverijns; Steven Dymarkowski; Frederik De Keyzer; Vincent Vandecaveye
Journal:  Eur Radiol       Date:  2013-12-11       Impact factor: 5.315

9.  Diagnostic and prognostic evaluation of fluorodeoxyglucose positron emission tomography/computed tomography and its correlation with serum cancer antigen-125 (CA125) in a large cohort of ovarian cancer patients.

Authors:  Laura Evangelista; Maurizia Dalla Palma; Michele Gregianin; Margherita Nardin; Anna Roma; Maria Ornella Nicoletto; Giovanni Battista Nardelli; Vittorina Zagonel
Journal:  J Turk Ger Gynecol Assoc       Date:  2015-08-06

10.  Impact of pre-operative positron emission tomography in gallbladder cancer.

Authors:  Universe Leung; Neeta Pandit-Taskar; Carlos U Corvera; Michael I D'Angelica; Peter J Allen; T Peter Kingham; Ronald P DeMatteo; William R Jarnagin; Yuman Fong
Journal:  HPB (Oxford)       Date:  2014-06-04       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.